# Secretome Therapeutics

> Clinical-stage biotechnology company (formerly NeoProgen, founded 2018) developing allogeneic,
> off-the-shelf regenerative therapies derived from neonatal cardiac progenitor cells (nCPCs).
> Lead candidate STM-01 and the cell-free secretome STM-2 are in Phase 1 study for heart failure
> with preserved ejection fraction (HFpEF), dilated cardiomyopathy (DCM) and Duchenne muscular
> dystrophy associated cardiomyopathy.

## Important for agents

- Secretome Therapeutics publishes **no API, SDK, developer portal, webhook surface or
  machine-readable contract** of any kind. There is nothing here to call.
- The corporate site (secretometherapeutics.com) runs on the VendorGroup/Kscope investor-relations
  platform, which returns **HTTP 200 with the homepage HTML for every unknown path**. Do not treat
  a 200 from this host as evidence that a document exists — check the body. `/llms.txt`,
  `/robots.txt`, `/sitemap.xml`, `/openapi.json`, `/graphql` and all `/.well-known/*` paths all
  answer this way and serve nothing.
- This file is GENERATED by API Evangelist from the catalog profile. It is not published by
  Secretome Therapeutics and is not served from their domain.

## Company pages

- [Home](https://secretometherapeutics.com/): Company overview, pipeline entry point, expanded-access policy.
- [Our Science](https://secretometherapeutics.com/our-science): nCPC mechanism of action — antiapoptotic and pro-angiogenic activity; pipeline section at /our-science#pipeline.
- [Patients](https://secretometherapeutics.com/patients): Patient information and clinical trial guidance.
- [Team](https://secretometherapeutics.com/team): Leadership and scientific team.
- [News and Publications](https://secretometherapeutics.com/news-publications): Company news and peer-reviewed publications.
- [Press Releases](https://secretometherapeutics.com/press-releases): Corporate press releases (content is loaded client-side by the IR platform).
- [Contact](https://secretometherapeutics.com/contact): Company contact form; info@secretometx.com.

## Legal

- [Terms of Service](https://secretometherapeutics.com/terms)
- [Privacy Policy](https://secretometherapeutics.com/privacy-policy)

## External references

- [ClinicalTrials.gov](https://clinicaltrials.gov): The company directs patients and physicians here for its HFpEF and DCM Phase 1 studies; trial records are published by NIH, not by Secretome Therapeutics.

## API Evangelist profile artifacts

- [security/secretome-therapeutics-domain-security.yml](security/secretome-therapeutics-domain-security.yml): Probed TLS/HSTS/DNSSEC/CAA/SPF/DMARC posture for secretometherapeutics.com.
- [well-known/secretome-therapeutics-well-known.yml](well-known/secretome-therapeutics-well-known.yml): Probe record for every /.well-known/ path — all soft-404s.